You are such a fool. Hubris rarely pays sh+thead.....................................As for an example, there are many. But you want just ONE, go back and check HGSI.
Stock action right before a binary event in bio's says nothing about the outcome of said event. If you ever bought a bio before, you would know it just aint that easy. Yes, there is plenty of stupidity and nonsense here to go around and your post seems to typify both very well.
Hey smalls, vaso is a tough hold right now for long termers, but there seems to be some serious support around this 25 cent level. Yes, there was that one block from a disillusioned seller around .24, but large bid resurfaced near close over 25 cents again. IT has been the same for a while now. Seller hitting bids but bids coming back around .25. VASO buyback should be out of money now. So, those bids may be from real buyer. We shall see.
As far as a near term catalyst, the obvious one is an announcement on GE extension. And as always, news on CED or PMA or CMS or trials could come at anytime; or not. I think, for better or worse, they are really gearing up for an acquisition. There is no doubt, based on Leibermans comments at the Meeting, they have looked at many with investment bankers. Lets hope they can do it right, as buying growth seems to be the order of the day in the market.
Are you kidding me chsacs. The stock hasn't had an up day(other than painting the tape like today) since the 4Q announcement and CC. It has been relentless selling. And it is not whining to say the reason for this 50% haircut is Ma and the BOD. Do you have any facts that say otherwise? Maybe you think like Garth that selloff is related to the whole medical device sector(up big now) or some dilution done years ago.
Ma should own this performance instead of making constant excuses. We all should make 600k a year for this extreme incompetence.
Vaso needs to go back to buyback or do a large acquisition. Doing nothing is not a strategy. Lets go boys, earn those fat salaries. Wake up Ma
John, why make a joke out of my example? Vaso should do a seismic, transformational acquisition. Now, as these type of deals are being rewarded is the time to do it. Lieberman had implied they have been talking to investment bankers. So, they don't want to do buyback and they don't seem to care much about eecp. They think they can swim with the big boys, so do it.
DNDN is a failed prostate cancer bio that charges 100k for a few months of extra life. Give me a break.
Lots of companys in china below the radar that Ma must know about. He has already made Vaso, for better or worse, a Chinese company. That's in his wheel house. Lets go BOD and Ma. The only thing off limits here is the status quo.
If done correctly and soon, stock would really take off....................Buy some Growth
Well, looks like buyback falling on deaf ears. Vaso wants to make an acquisition, lets do it. But, do it big. Its clear we are going nowhere in terms of stock price. So do a BIOF: a 30 million dollar company with 100k in revs and 10 mil in cash. They are doing an acquisition for 275 mil. And stock up 2 points.
Market is rewarding buying growth..................Lets do it then
Fire this frog. Stock cant even rally with the rest of the bios and is way off highs. What an underperformer.
The guy turns down buyouts over the years so he can keep his fat cat salary. SOS
Vaso had no problem having someone at the company comment on the Stony Brook trial when it was first announced. But now, after a year, they will not give any news or update on progress or lack of progress. They say they don't want to bias an independent trial. This is pure Ma-speak and is just another excuse for lack of transparency here.
There is ZERO doubt that vaso knows what the problem is here, yet they refuse to share anything with shareholders. You know Ma must talk with Poon.
These trials were a big reason many long termers stayed with vaso and indeed added to shares. Now, just like India or CMS upgrade............................nothing. Is this why we pay Ma 600 grand and 100 grand in expenses????? Is this the value added that one would expect a highly paid CEO to bring? Is this what our compensation committee, lead by big mouth, overpaid Castle, sees when he says Ma is actually UNDERPAID by 100k. Its all one big, indefensible disgrace.
WESTBURY, N.Y., June 12, 2013 /PRNewswire/ -- Vasomedical, Inc. (OTC BB: VASO) announced today that Stony Brook Medicine's new Center for Cardiovascular Wellness and Preventive Research will feature the Company's EECP Therapy devices in the treatment of vascular endothelial dysfunction and in preventing the onset and progression of cerebral, coronary and peripheral vascular diseases.
According to Stony Brook Medicine's public announcement, the center was made possible as a result of several recent philanthropic gifts that were matched dollar for dollar by the Simons Foundation Challenge Grant, doubling their impact and totaling in excess of $7.5 million. The center will conduct groundbreaking research into cardiovascular health and to identify and develop new options for the treatment and prevention of coronary artery disease, heart failure and Alzheimer's disease. It will focus on EECP Therapy, an FDA-cleared, non-invasive therapeutic device manufactured by Vasomedical that reduces the workload of the heart and increases blood flow to the coronary arteries and other organs of the body.
Dr. Michael Poon, a professor of Emergency Medicine, Medicine (Cardiology), and Radiology, and Director of Advanced Cardiovascular Imaging at Stony Brook Medicine, is leading the research efforts at the new center. Research at the center could ultimately benefit not only patients with or at risk of developing coronary artery disease, but also heart failure and Alzheimer's disease, which are disorders that could be caused by vascular endothelial dysfunction, as the results are translated into new approaches to patient care and disease prevention. Additional exploratory research will examine the use of EECP Therapy in preventing muscle soreness and injury in elite athletes.
"At Vasomedical, we have been proponents of EECP Therapy for almost 20 years, seeing incredible benefits to many different patient populations. Stony Brook University was among the first in the United States
These are the words of Ray Dalio,(Wall St Journal today) head of the largest hedge fund in the world. His connection to vaso is that he financed a new heart center at Stony Brook to study effects of EECP. A year into this 2 year initiative, no studies have even started. When Ma commented on this, he said he didn't know why and if shareholders wanted to know "they should call themselves to find out."
Dalio says all businesses, economies, and even people, are just machines. And its very clear, he would classify the corporate Vasomedical as a broken machine. "A firm should encourage everyone to accept unvarnished criticism as a treasured opportunity to learn and solve problems." But as shareholder meeting, vaso's BOD and Ma dismissed critics by saying they didn't know what they were talking about(we are just traders) or deflecting by congratulating themselves on saving company over 4 years ago with GEHC. BOD and Ma always respond with the "lower level you", and therefore nothing is learned and no positive change can occur; no truth and certainly no transparency at Vaso.....................................................
Long term shareholders deserve better.
It is possible that they have been restrained from such purchases if ongoing discussions have been held for the sale of the company.
Simple answer................NO. They don't buy cause they get free stock grants(at shareholder expense). And in the case of Ma, he get free stock AND options to buy at much lower than market prices. Pigs at the trough.
Yea, large bid at .26 kept getting hit, but then refreshed with more size. It certainly had the look of the previous company buybacks, but I don't know how much, if any, money if left. The last update was less than 100k and that was a while ago.
Over 2000 of next weeks june 22 calls bought at .25. Offer now .3 That's where you would want to be when news hits..............10 bagger
Hearing the exact opposite on DJ2. Announcement within the week. Lots of OTM near term call action. Huge leverage on pending report.
These 70's were being bought the other day in size at a 1/2. The question with this 1100 contract transaction is, was the original buyer booking profit or was someone chasing price higher. The OI tells the story, as OI went from 4900 contracts to over 8000; new opening transactions. No profit taking, just new buying. Very bullish for news short term......................
Income investors here wake up to a big decrease in dividend, to say nothing of the loss of monthly cash flow. And they do this by selling their best division. I guess they had no choice.
New dividend will be secure for some time now, but wont attract new investors without at least a 10% rate.............5 dollars????